Shuttle Pharma closes second tranche of $1.3M note offering, total $790K raised

Shuttle Pharmaceuticals Holdings, Inc.

Second closing on Oct 21 added $220K net proceeds ($231,579 in Notes) from two accredited investors.
Investors received 88,544 warrants exercisable at $1.49/share (125% of prior closing price).
CEO Dr. Anatoly Dritschilo invested $237,500 in the first closing on Oct 14.
Total offering gross proceeds $790K; Notes carry 5% OID and are senior secured convertible.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.